The Historical BMI Rule One of the most clinically significant details of the Medicare GLP-1 Bridge, and one that prescribers must understand clearly, is that the relevant BMI is measured at the time of therapy initiation, not at the time of the prior authorisation request
For example, while Gln and the Gln-Glu cycle are believed to regulate Glu, an increased cycle turnover could mitigate excessive glutamatergic activity and maintain a balanced excitatory tone [15, 61]
Avoid use by pregnant and lactating woman keep out of reach of children
The absence of growth hormone-related side effects, no impact on glucose metabolism or IGF-1, and favorable comparison to other fat loss interventions make it a valuable option for appropriate individuals
The three approved zones each have enough subcutaneous fat to absorb the medication properly
Engagement retention: D30 Engagement based on Noom app engagement data for December 2025 Noom Microdose GLP-1 Rx Program users, based on their first-ever log-in date
